107 related articles for article (PubMed ID: 12521208)
21. [Successful use of angiotensin II receptor antagonist (losartan) in a patient with scleroderma renal crisis].
Hasegawa S; Iesato K; Tsukahara T; Yamamoto S; Kondou Y; Ogawa M; Ueda S
Nihon Jinzo Gakkai Shi; 2000 Feb; 42(2):60-5. PubMed ID: 10771577
[TBL] [Abstract][Full Text] [Related]
22. Antihypertensive and renoprotective efficacy and safety of losartan. A long-term study in children with renal disorders.
Ellis D; Moritz ML; Vats A; Janosky JE
Am J Hypertens; 2004 Oct; 17(10):928-35. PubMed ID: 15485756
[TBL] [Abstract][Full Text] [Related]
23. IgA nephropathy with severe chronic renal failure: a randomized controlled trial of corticosteroids and azathioprine.
Pozzi C; Andrulli S; Pani A; Scaini P; Roccatello D; Fogazzi G; Pecchini P; Rustichelli R; Finocchiaro P; Del Vecchio L; Locatelli F
J Nephrol; 2013; 26(1):86-93. PubMed ID: 22460183
[TBL] [Abstract][Full Text] [Related]
24. [Successful treatment of combination therapy using an angiotensin-converting enzyme inhibitor and an angiotensin II receptor blocker in a patient with IgA nephropathy].
Horino T; Ito H; Tanimoto N; Yoshida T; Sasaoka A; Chijiwa T; Hosokawa T; Hashimoto K
Nihon Jinzo Gakkai Shi; 2003; 45(2):104-8. PubMed ID: 12703406
[TBL] [Abstract][Full Text] [Related]
25. Abelmoschus manihot - a traditional Chinese medicine versus losartan potassium for treating IgA nephropathy: study protocol for a randomized controlled trial.
Li P; Chen YZ; Lin HL; Ni ZH; Zhan YL; Wang R; Yang HT; Fang JA; Wang NS; Li WG; Sun XF; Chen XM
Trials; 2017 Apr; 18(1):170. PubMed ID: 28395659
[TBL] [Abstract][Full Text] [Related]
26. Acute effects of angiotensin II receptor antagonist on autoregulation of zonal glomerular filtration rate in renovascular hypertensive rats.
Wang X; Aukland K; Iversen BM
Kidney Blood Press Res; 1997; 20(4):225-32. PubMed ID: 9398027
[TBL] [Abstract][Full Text] [Related]
27. Beneficial effects of high-dose losartan in IgA nephritis.
Woo KT; Chan CM; Tan HK; Choong HL; Foo M; Vathsala A; Lee EJ; Tan CC; Lee GS; Tan SH; Lim CH; Chiang GS; Fook-Chong S; Wong SK
Clin Nephrol; 2009 Jun; 71(6):617-24. PubMed ID: 19473629
[TBL] [Abstract][Full Text] [Related]
28. [Effect of angiotensin II receptor antagonist (losartan) on renal function, serum potassium and blood pressure in patients with advanced renal failure: differences between patients with a serum creatinine (SCr) level higher than 3 mg/dl and those with a lower SCr level].
Nakayama M; Tanno Y; Otsuka Y; Takahashi H; Ikeda M; Katoh N; Yokoyama K; Yamamoto H; Tokutome G; Hosoya T
Nihon Jinzo Gakkai Shi; 2002 Oct; 44(7):530-6. PubMed ID: 12476589
[TBL] [Abstract][Full Text] [Related]
29. Add-on angiotensin II receptor blockade lowers urinary transforming growth factor-beta levels.
Agarwal R; Siva S; Dunn SR; Sharma K
Am J Kidney Dis; 2002 Mar; 39(3):486-92. PubMed ID: 11877567
[TBL] [Abstract][Full Text] [Related]
30. Hydroxychloroquine alleviates persistent proteinuria in IgA nephropathy.
Gao R; Wu W; Wen Y; Li X
Int Urol Nephrol; 2017 Jul; 49(7):1233-1241. PubMed ID: 28349446
[TBL] [Abstract][Full Text] [Related]
31. Treatment of severe IgA nephropathy with omega-3 fatty acids: the effect of a "very low dose" regimen.
Alexopoulos E; Stangou M; Pantzaki A; Kirmizis D; Memmos D
Ren Fail; 2004 Jul; 26(4):453-9. PubMed ID: 15462115
[TBL] [Abstract][Full Text] [Related]
32. Angiotensin II type 1 (AT1) receptor antagonists in the treatment of hypertension after renal transplantation.
Holgado R; Anaya F; Del Castillo D
Nephrol Dial Transplant; 2001; 16 Suppl 1():117-20. PubMed ID: 11369838
[TBL] [Abstract][Full Text] [Related]
33. Advances in the treatment of diabetic renal disease: focus on losartan.
Rayner B
Curr Med Res Opin; 2004 Mar; 20(3):333-40. PubMed ID: 15025842
[TBL] [Abstract][Full Text] [Related]
34. ATRA therapy restores normal renal function and renal reserve and prevents renal failure.
Woo KT; Lau YK; Chan CM; Wong KS
Ann Acad Med Singap; 2005 Jan; 34(1):52-9. PubMed ID: 15726220
[TBL] [Abstract][Full Text] [Related]
35. The effects of losartan on renal function in the newborn rabbit.
Prevot A; Mosig D; Guignard JP
Pediatr Res; 2002 Jun; 51(6):728-32. PubMed ID: 12032268
[TBL] [Abstract][Full Text] [Related]
36. The effects of cytotoxic therapy in progressive IgA nephropathy.
Shin JH; Lee JE; Park JH; Lim S; Jang HR; Kwon GY; Huh W; Jung SH; Kim YG; Oh HY; Kim DJ
Ann Med; 2016; 48(3):171-81. PubMed ID: 27031662
[TBL] [Abstract][Full Text] [Related]
37. Prognostic factors and therapy assessment of IgA nephropathy: report from a single unit in iran.
Soleymanian T; Najafi I; Salimi BH; Broomand B
Ren Fail; 2011; 33(6):572-7. PubMed ID: 21663387
[TBL] [Abstract][Full Text] [Related]
38. Effect of losartan treatment on the proteinuria in normotensive patients having proteinuria due to secondary amyloidosis.
Odabas AR; Cetinkaya R; Selcuk Y; Bilen H
Ups J Med Sci; 2001; 106(3):183-8. PubMed ID: 12166510
[TBL] [Abstract][Full Text] [Related]
39. Combination of angiotensin II receptor antagonist with calcium channel blocker or diuretic as antihypertensive therapy for patients with chronic kidney disease.
Ishimitsu T; Ohno E; Nakano N; Furukata S; Akashiba A; Minami J; Numabe A; Matsuoka H
Clin Exp Hypertens; 2011; 33(6):366-72. PubMed ID: 21797795
[TBL] [Abstract][Full Text] [Related]
40. Short-term effects of angiotensin II receptor blockade in patients with primary glomerulonephritis: pilot study.
Tylicki L; Renke M; Rutkowski P; Rutkowski B
J Ren Nutr; 2002 Apr; 12(2):122-5. PubMed ID: 11953926
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
